Search

Search Constraints

You searched for: Author/Creator Hobson, Nicholas

Search Results

1. A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH). (18th November 2021)

2. A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH). (18th November 2021)

3. A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH). Issue 3 (19th January 2021)

4. Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Issue 6 (1st December 2019)

5. Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Issue 6 (26th November 2018)

6. Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project. Issue 12 (16th September 2021)

7. Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project. Issue 12 (December 2021)

8. Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage. Issue 11 (November 2021)

9. Perfusion and Permeability MRI Predicts Future Cavernous Angioma Hemorrhage and Growth. Issue 5 (24th September 2021)

10. Phantom validation of quantitative susceptibility and dynamic contrast‐enhanced permeability MR sequences across instruments and sites. Issue 4 (12th September 2019)